Niquitin
Niquitin is a brand of nicotine replacement therapy (NRT) products designed to help individuals quit smoking. The brand is owned by GlaxoSmithKline, a British multinational pharmaceutical company. Niquitin products are available in various forms, including patches, lozenges, and mini lozenges.
History[edit | edit source]
Niquitin was developed by GlaxoSmithKline as part of their commitment to global health improvement. The brand was launched with the aim of providing effective and convenient nicotine replacement options for smokers looking to quit.
Products[edit | edit source]
Niquitin offers a range of products, each designed to cater to the unique needs of individuals at different stages of their quit journey.
Niquitin Patches[edit | edit source]
Niquitin Patches are designed to provide a steady stream of nicotine throughout the day. They are available in different strengths to cater to the needs of heavy and light smokers.
Niquitin Lozenges[edit | edit source]
Niquitin Lozenges are sugar-free lozenges that provide a burst of nicotine to help manage sudden cravings. They are available in different strengths and flavors.
Niquitin Mini Lozenges[edit | edit source]
Niquitin Mini Lozenges are smaller, more discreet lozenges that provide a quick nicotine hit. They are ideal for those who prefer a more subtle form of NRT.
Usage[edit | edit source]
Niquitin products are used as part of a comprehensive quit plan, which may also include support from healthcare professionals and behavioral changes. The appropriate product and strength are determined based on the individual's smoking habits and nicotine dependence.
Effectiveness[edit | edit source]
Numerous studies have shown that NRT products like Niquitin can significantly increase the chances of successfully quitting smoking when used as directed. However, as with all NRT products, Niquitin is not a magic cure and requires commitment and willpower from the user.
Side Effects[edit | edit source]
As with all NRT products, Niquitin can cause side effects, including skin irritation (for patches), mouth ulcers, and gastrointestinal disturbances. Users are advised to consult their healthcare provider if they experience severe or persistent side effects.
See Also[edit | edit source]
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
